Article 16, of the Medical Device Directive delineates the requirements for “Notified Bodies.” The notified body is authorized to issue certification, and can take away the certification; the CE Mark of registration belongs to the notified body; if a certificate is withdrawn, manufacturers must remove the CE Mark of conformity; and Competent Authorities can suspend or revoke a certificate if the devices are found to be unsafe or ineffective.
Article 15 provides guidelines for device manufacturers that have product or are planning to introduce product, into an EU Member State, for the purpose of conducting a clinical investigation. Failure to comply with this will result in device manufacturers failing to obtain approval to pursue clinical investigations within the EU, and in today’s increasingly complex medical device market, not performing a clinical investigation will result in device manufacturers being shut out of the European market.
Article 14b, of Council Directive 93/42/EEC, a.k.a., the Medical Device Directive (MDD) delineates the requirements for “Particular Health Monitoring Measures.” There are two takeaways from this edition of DG: One, a robust design and development process will lead to medical devices that are safe and effective; and two, devices that are safe and effective and meet their essential requirements seldom, if ever, will run afoul of Article 14b of the MDD.
Article 14a, of Council Directive 93/42/EEC delineates the requirements for “European Databank.” This week’s edition of Devine Guidance relates to the European Union (EU) and their need to develop a standardized format for data collection associated with medical devices; and a receptacle for collecting voluminous amounts of data. The takeaway for device manufacturers is that the EU continues with their pursuit of standardization in supporting the establishment of effective data management, with the devel…
The takeaway for this week’s edition is extremely simple; however, understanding Article 14 is vitally important. Device manufacturers need to retain a European Authorized Representative in order to place medical devices into commerce in the EU with the following in place: a contract with the EU Authorized Rep; an accurate product list on file with the EU Authorized Rep; and the EU Authorized Rep’s address on the product labeling.
This week focuses on Article 13 of the Medical Device Directive that delineates the requirements for “ Decisions with Regard to Classification and Derogation Clause .” The only takeaway the doctor is offering from this edition of DG is to read the Directive and understand the implications each of the Articles and Annexes have on your organization, as understanding the context of device regulations, or the MDD, is synonymous with sustaining regulatory compliance.
Article 12a of the Medical Device Directive (MDD) delineates the requirements for “Reprocessing of Medical Devices.” Is the practice of reprocessing single-use devices safe and effective? Generally speaking, reprocessors believe the practice is safe, device manufacturers, not so much. The reprocessing of medical devices is a widely-accepted practice; however, the doctor questions the validity or reprocessing of devices clearly marketed as single-use, by the manufacturer.
Article 12, of Council Directive 93/42/EEC, a.k.a., the Medical Device Directive delineates the requirements for “Particular Procedure for Systems and Procedure Packs and Procedure for Sterilization Conformity Assessment Procedures.” Article 12 is all about declarations and compliance with Annex II (EC Declaration of Conformity – Full Quality Assurance System) and Annex V (EC Declaration of Conformity – Production Quality Assurance).
Article 11 of the Medical Device Directive aligns the actual classification of devices with the applicable Annex in order to affix a CE mark containing the notified body’s registration number. There are three important takeaways from this week: one, device manufacturers need to understand the link between device classification and the appropriate Annexes; two, notified bodies are permitted to grant application extensions for up to five years and; three, the Competent Authority can grant device entry…
This week we discuss Article 10 of the Medical Device Directive which establishes the reporting requirements for incidents within the European Union, also known as vigilance reports. The key takeaway is that there is an incident reporting system alive and well within the EU. Device manufacturers are expected to act immediately when reports of patient and user injury or death occur.